Evidence map›Paper›PMID 42094399›Full record

ArticlebioRxiv : the preprint server for biology2026

Selective Editing and Functionalization of the Mammalian Lipidome.

Binyou Wang, Lukas Lüthy, Logan Tenney, Leo Qi, Takeshi Harayama, Kim Ekroos, Johannes Morstein

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Binyou WangDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Lukas LüthyDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Logan TenneyDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Leo QiDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Takeshi HarayamaInstitut de Pharmacologie Moléculaire et Cellulaire, Université Côte d'Azur - CNRS UMR7275 - Inserm U1323, Valbonne, France.
Kim EkroosLipidomics Consulting Ltd., Esbo, Finland.
Johannes MorsteinDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.

Funding

Targeting Cancer at the Protein-Membrane InterfaceR00CA277358 · NCI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI Johannes Morstein · 2025 to 2026
$498k
NCI NIH HHS R00 CA277358
6 · The paper itself

Abstract

Lipids exhibit extraordinary molecular diversity, yet tools to selectively manipulate defined lipid classes in living cells are lacking. Here we show that lipid tail structure biases metabolic fate, enabling the design of synthetic lipid analogs with programmable metabolic selectivity. This approach enables selective cellular production of distinct lipid species or subclasses, including types of neutral lipids, phospholipids, sphingolipids, and ether lipids, without genetic or enzymatic perturbation. We further couple metabolic selectivity to chemical functionalization using bifunctional lipids, in which one modification directs metabolic flux and a second enables bioorthogonal tagging. Using this strategy, we achieve selective

Identifiers

PMID42094399
PMCPMC13142499

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.